Working… Menu
Trial record 1 of 1 for:    NCT03230292
Previous Study | Return to List | Next Study

A Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Adult Patients With Chronic Plaque Psoriasis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03230292
Recruitment Status : Completed
First Posted : July 26, 2017
Last Update Posted : July 17, 2020
Information provided by (Responsible Party):
UCB Pharma ( UCB Biopharma S.P.R.L. )

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : March 6, 2019
Actual Study Completion Date : March 6, 2019
Certification/Extension First Submitted : March 5, 2020